File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Antiviral treatment for chronic hepatitis B

TitleAntiviral treatment for chronic hepatitis B
Authors
KeywordsAntiviral therapy
Chronic hepatitis B
Immunomodulator
Viral suppressor
Issue Date1997
PublisherHong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org/resources/supp.html
Citation
Hong Kong Medical Journal, 1997, v. 3 n. 3, p. 289-296 How to Cite?
AbstractAn updated review of the antiviral agents currently available or under trial for the treatment of chronic hepatitis B is presented. There are two broad groups: (1) immunomodulators including interferon α (which also has a direct antiviral effect), thymosin α1 and Theradigm-HBV and (2) viral suppressors such as famciclovir and lamivudine. These agents are still in clinical trial worldwide, singly or in combination. Their long term efficacy in the treatment of hepatitis B remains to be evaluated.
Persistent Identifierhttp://hdl.handle.net/10722/53408
ISSN
2015 Impact Factor: 0.887
2015 SCImago Journal Rankings: 0.279

 

DC FieldValueLanguage
dc.contributor.authorLai, CLen_HK
dc.contributor.authorWu, PCen_HK
dc.date.accessioned2009-04-03T07:19:00Z-
dc.date.available2009-04-03T07:19:00Z-
dc.date.issued1997en_HK
dc.identifier.citationHong Kong Medical Journal, 1997, v. 3 n. 3, p. 289-296en_HK
dc.identifier.issn1024-2708en_HK
dc.identifier.urihttp://hdl.handle.net/10722/53408-
dc.description.abstractAn updated review of the antiviral agents currently available or under trial for the treatment of chronic hepatitis B is presented. There are two broad groups: (1) immunomodulators including interferon α (which also has a direct antiviral effect), thymosin α1 and Theradigm-HBV and (2) viral suppressors such as famciclovir and lamivudine. These agents are still in clinical trial worldwide, singly or in combination. Their long term efficacy in the treatment of hepatitis B remains to be evaluated.en_HK
dc.languageengen_HK
dc.publisherHong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org/resources/supp.htmlen_HK
dc.relation.ispartofHong Kong Medical Journalen_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.rightsHong Kong Medical Journal. Copyright © Hong Kong Medical Association.en_HK
dc.subjectAntiviral therapyen_HK
dc.subjectChronic hepatitis Ben_HK
dc.subjectImmunomodulatoren_HK
dc.subjectViral suppressoren_HK
dc.titleAntiviral treatment for chronic hepatitis Ben_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1024-2708&volume=3&issue=3&spage=289&epage=296&date=1997&atitle=Antiviral+treatment+for+chronic+hepatitis+Ben_HK
dc.identifier.emailLai, CL:hrmelcl@hku.hken_HK
dc.identifier.authorityLai, CL=rp00314en_HK
dc.description.naturepublished_or_final_versionen_HK
dc.identifier.scopuseid_2-s2.0-0031461205en_HK
dc.identifier.hkuros37180-
dc.identifier.volume3en_HK
dc.identifier.issue3en_HK
dc.identifier.spage289en_HK
dc.identifier.epage296en_HK
dc.publisher.placeHong Kongen_HK
dc.identifier.scopusauthoridLai, CL=7403086396en_HK
dc.identifier.scopusauthoridWu, PC=7403119323en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats